ADE |
Antibody-Dependent Enhancement |
ADCP |
Antibody-Dependent Cellular Phagocytosis |
ADCC |
Antibody-Dependent Cellular Cytotoxicity |
AMCD |
Antibody-Mediated Complement Deposition |
bNAbs |
Broadly Neutralising Antibodies |
CDC |
Complement Dependent Cytotoxicity |
CMV |
Cytomegalovirus |
DENV |
Dengue Virus |
ELISA |
Enzyme-Linked Immunosorbent Assay |
Fab |
Fragment Antigen Binding |
Fc |
Fragment Crystallisable |
FcR |
Fragment Crystallisable Receptor |
HCV |
Hepatitis C Virus |
HA |
Hemagglutinin |
HIV |
Human Immunodeficiency Virus |
HPV |
Human Papilloma Virus |
IAV |
Influenza A Virus |
ITAM |
Immunoreceptor Tyrosine-Based Activation Motif |
LCMV |
Lymphocytic Choriomeningitis Virus |
MAC |
Membrane Attack Complex |
MARV |
Marburg virus |
mAb |
Monoclonal Antibody |
MHC |
Major Histocompatibility Complex |
Nab |
Neutralising Antibody |
NK cell |
Natural Killer Cell |
nNAb |
Non-neutralising Antibody |
pIgR |
Poly Ig Receptor |
RBD |
Receptor Binding Domain |
ScFv |
Single Chain Variable Fragment |